Rhumbline Advisers BIOSPECIFICS TECHNOLOGIES CORP Transaction History

Rhumbline Advisers

$109 Billion
Q4 2024

Shares

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2020 Feb 10, 2021	SELL	N/A	-7,117 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	N/A	-1,095 Reduced 13.33%	7,117 $376,000
Q2 2020 Aug 13, 2020	BUY	N/A	578 Added 7.57%	8,212 $503,000
Q4 2019 Feb 05, 2020	BUY	N/A	59 Added 0.78%	7,634 $435,000
Q3 2019 Oct 23, 2019	SELL	N/A	-75 Reduced 0.98%	7,575 $405,000
Q2 2019 Aug 14, 2019	BUY	N/A	344 Added 4.71%	7,650 $457,000
Q1 2019 May 01, 2019	SELL	N/A	-224 Reduced 2.97%	7,306 $455,000
Q4 2018 Jan 31, 2019	BUY	N/A	2,492 Added 49.46%	7,530 $456,000
Q3 2018 Nov 07, 2018	SELL	N/A	-300 Reduced 5.62%	5,038 $295,000
Q2 2018 Aug 06, 2018	BUY	N/A	355 Added 7.12%	5,338 $239,000
Q1 2018 May 02, 2018	SELL	N/A	-175 Reduced 3.39%	4,983 $221,000
Q4 2017 Feb 09, 2018	SELL	N/A	-1,619 Reduced 23.89%	5,158 $223,000
Q3 2017 Nov 06, 2017	BUY	N/A	6,777	6,777 $315,000

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.